OP
ARRY

Omni Partners’s Array Biopharma Inc ARRY Stock Holding History

Omni Partners’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,585,000
Closed -$73.4M – 45
2019
Q2 		$73.4M Buy
+1,585,000
New +$44.5M 3.87% 11

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Omni Partners's ARRY Position: Q3 2019 in Review

Omni Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 1,585,000 shares — an estimated $73.4M sold.

Omni Partners first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $73.4M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Omni Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Omni Partners sold 1,585,000 Array Biopharma Inc shares in Q3 2019, an estimated $73.4M.
  • Omni Partners first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Omni Partners's Array Biopharma Inc position peaked at $73.4M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Omni Partners's 13F filing for Q3 2019, filed 14 Nov 2019.